Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Conditions: Atrial Fibrillation Paroxysmal; Atrial Fibrillation, Persistent; Cardiac Arrhythmia; Ablation Interventions: Device: Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Sponsors: Abbott Medical Devices Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arrhythmia | Atrial Fibrillation | Cardiac Arrhythmia | Medical Devices | Research | Study